352 related articles for article (PubMed ID: 18318438)
1. Activation of liver X receptor sensitizes mice to gallbladder cholesterol crystallization.
Uppal H; Zhai Y; Gangopadhyay A; Khadem S; Ren S; Moser JA; Xie W
Hepatology; 2008 Apr; 47(4):1331-42. PubMed ID: 18318438
[TBL] [Abstract][Full Text] [Related]
2. The G protein-coupled receptor G2A: involvement in hepatic lipid metabolism and gallstone formation in mice.
Johnson LE; Elias MS; Bolick DT; Skaflen MD; Green RM; Hedrick CC
Hepatology; 2008 Oct; 48(4):1138-48. PubMed ID: 18821587
[TBL] [Abstract][Full Text] [Related]
3. CAV1 Prevents Gallbladder Cholesterol Crystallization by Regulating Biosynthesis and Transport of Bile Salts.
Xu G; Li Y; Jiang X; Chen H
J Cell Biochem; 2016 Sep; 117(9):2118-27. PubMed ID: 26875794
[TBL] [Abstract][Full Text] [Related]
4. PXR prevents cholesterol gallstone disease by regulating biosynthesis and transport of bile salts.
He J; Nishida S; Xu M; Makishima M; Xie W
Gastroenterology; 2011 Jun; 140(7):2095-106. PubMed ID: 21354151
[TBL] [Abstract][Full Text] [Related]
5. Activation of Constitutive Androstane Receptor Prevents Cholesterol Gallstone Formation.
Cheng S; Zou M; Liu Q; Kuang J; Shen J; Pu S; Chen L; Li H; Wu T; Li R; Li Y; Jiang W; Zhang Z; He J
Am J Pathol; 2017 Apr; 187(4):808-818. PubMed ID: 28283178
[TBL] [Abstract][Full Text] [Related]
6. Ezetimibe prevents cholesterol gallstone formation in mice.
Zúñiga S; Molina H; Azocar L; Amigo L; Nervi F; Pimentel F; Jarufe N; Arrese M; Lammert F; Miquel JF
Liver Int; 2008 Aug; 28(7):935-47. PubMed ID: 18783541
[TBL] [Abstract][Full Text] [Related]
7. Effect of ezetimibe on the prevention and dissolution of cholesterol gallstones.
Wang HH; Portincasa P; Mendez-Sanchez N; Uribe M; Wang DQ
Gastroenterology; 2008 Jun; 134(7):2101-10. PubMed ID: 18442485
[TBL] [Abstract][Full Text] [Related]
8. Piperine prevents cholesterol gallstones formation in mice.
Song XY; Xu S; Hu JF; Tang J; Chu SF; Liu H; Han N; Li JW; Zhang DM; Li YT; Chen NH
Eur J Pharmacol; 2015 Mar; 751():112-7. PubMed ID: 25645812
[TBL] [Abstract][Full Text] [Related]
9. Nuclear receptors and cholesterol metabolism in the intestine.
Moschetta A
Atheroscler Suppl; 2015 Feb; 17():9-11. PubMed ID: 25659870
[TBL] [Abstract][Full Text] [Related]
10. The cholecystokinin-1 receptor antagonist devazepide increases cholesterol cholelithogenesis in mice.
Wang HH; Portincasa P; Wang DQ
Eur J Clin Invest; 2016 Feb; 46(2):158-69. PubMed ID: 26683129
[TBL] [Abstract][Full Text] [Related]
11. Inactivation of hepatic microsomal triglyceride transfer protein protects mice from diet-induced gallstones.
Amigo L; Castro J; Miquel JF; Zanlungo S; Young S; Nervi F
Gastroenterology; 2006 Dec; 131(6):1870-8. PubMed ID: 17064699
[TBL] [Abstract][Full Text] [Related]
12. Ezetimibe prevents the formation of oestrogen-induced cholesterol gallstones in mice.
de Bari O; Wang HH; Portincasa P; Paik CN; Liu M; Wang DQ
Eur J Clin Invest; 2014 Dec; 44(12):1159-68. PubMed ID: 25303682
[TBL] [Abstract][Full Text] [Related]
13. Transgenic overexpression of Niemann-Pick C2 protein promotes cholesterol gallstone formation in mice.
Acuña M; González-Hódar L; Amigo L; Castro J; Morales MG; Cancino GI; Groen AK; Young J; Miquel JF; Zanlungo S
J Hepatol; 2016 Feb; 64(2):361-369. PubMed ID: 26453970
[TBL] [Abstract][Full Text] [Related]
14. Deficiency of Niemann-Pick C1 protein protects against diet-induced gallstone formation in mice.
Morales MG; Amigo L; Balboa E; Acuña M; Castro J; Molina H; Miquel JF; Nervi F; Rigotti A; Zanlungo S
Liver Int; 2010 Jul; 30(6):887-97. PubMed ID: 20408952
[TBL] [Abstract][Full Text] [Related]
15. Ezetimibe ameliorates cholecystosteatosis.
Mathur A; Walker JJ; Al-Azzawi HH; Lu D; Swartz-Basile DA; Nakeeb A; Pitt HA
Surgery; 2007 Aug; 142(2):228-33. PubMed ID: 17689690
[TBL] [Abstract][Full Text] [Related]
16. Pioglitazone prevents cholesterol gallstone formation through the regulation of cholesterol homeostasis in guinea pigs with a lithogenic diet.
Han T; Lv Y; Wang S; Hu T; Hong H; Fu Z
Lipids Health Dis; 2019 Dec; 18(1):218. PubMed ID: 31829191
[TBL] [Abstract][Full Text] [Related]
17. Combination of curcumin and piperine prevents formation of gallstones in C57BL6 mice fed on lithogenic diet: whether NPC1L1/SREBP2 participates in this process?
Li Y; Li M; Wu S; Tian Y
Lipids Health Dis; 2015 Sep; 14():100. PubMed ID: 26335572
[TBL] [Abstract][Full Text] [Related]
18. Glucagon-like peptide 1 analogue prevents cholesterol gallstone formation by modulating intestinal farnesoid X receptor activity.
Zhang Z; Du Z; Liu Q; Wu T; Tang Q; Zhang J; Huang C; Huang Y; Li R; Li Y; Zhao Y; Zhang G; Zhou J; Huang H; Fang Z; He J
Metabolism; 2021 May; 118():154728. PubMed ID: 33581130
[TBL] [Abstract][Full Text] [Related]
19. Prevention of cholesterol gallstone disease by schaftoside in lithogenic diet-induced C57BL/6 mouse model.
Liu M; Liu C; Chen H; Huang X; Zeng X; Zhou J; Mi S
Eur J Pharmacol; 2017 Nov; 815():1-9. PubMed ID: 28993159
[TBL] [Abstract][Full Text] [Related]
20. Hypothyroidism Increases Cholesterol Gallstone Prevalence in Mice by Elevated Hydrophobicity of Primary Bile Acids.
Kube I; Tardio LB; Hofmann U; Ghallab A; Hengstler JG; Führer D; Zwanziger D
Thyroid; 2021 Jun; 31(6):973-984. PubMed ID: 33231505
[No Abstract] [Full Text] [Related]
[Next] [New Search]
